Piano Carla, Losurdo Anna, Della Marca Giacomo, Solito Marcella, Calandra-Buonaura Giovanna, Provini Federica, Bentivoglio Anna Rita, Cortelli Pietro
Center for Parkinson Disease and Extrapyramidal Disorders, Movement Disorders Unit, Institute of Neurology, Catholic University, Rome, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical and NeuroMotor Sciences (DIBINEM), Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Sleep. 2015 Sep 1;38(9):1489-95. doi: 10.5665/sleep.4996.
To evaluate the sleep pattern and the motor activity during sleep in a cohort of patients affected by Huntington disease (HD).
Cross-sectional cohort study.
Sleep laboratory.
Thirty HD patients, 16 women and 14 men (mean age 57.3 ± 12.2 y); 30 matched healthy controls (mean age 56.5 ± 11.8 y).
Subjective sleep evaluation: Epworth Sleepiness Scale (ESS); Berlin's Questionnaire, interview for restless legs syndrome (RLS), questionnaire for REM sleep behavior disorder (RBD). Clinical evaluation: disease duration, clinical severity (unified Huntington disease motor rating scale [UHDMRS]), genetic tests. Laboratory-based full-night attended video-polysomnography (V-PSG).
The duration of the disease was 9.4 ± 4.4 y, UHMDRS score was 55.5 ± 23.4, CAG repeats were 44.3 ± 4.1. Body mass index was 21.9 ± 4.0 kg/m(2). No patients or caregivers reported poor sleep quality. Two patients reported symptoms of RLS. Eight patients had an ESS score ≥ 9. Eight patients had high risk of obstructive sleep apnea. At the RBD questionnaire, two patients had a pathological score. HD patients, compared to controls, showed shorter sleep, reduced sleep efficiency index, and increased arousals and awakenings. Four patients presented with sleep disordered breathing (SDB). Periodic limb movements (PLMs) during wake and sleep were observed in all patients. No episode of RBD was observed in the V-PSG recordings, and no patients showed rapid eye movement (REM) sleep without atonia. The disease duration correlated with ESS score (P < 0.02). UHMDRS correlated positively with the ESS score (P < 0.005), and negatively with the percentage of REM sleep.
Patients with Huntington disease showed a severe sleep disruption and a high prevalence of periodic limb movements, but no evidence of sleep disordered breathing or REM sleep behavior disorder.
评估一组亨廷顿病(HD)患者的睡眠模式及睡眠期间的运动活动。
横断面队列研究。
睡眠实验室。
30例HD患者,16名女性和14名男性(平均年龄57.3±12.2岁);30名匹配的健康对照者(平均年龄56.5±11.8岁)。
主观睡眠评估:爱泼沃斯思睡量表(ESS);柏林问卷、不安腿综合征(RLS)访谈、快速眼动睡眠行为障碍(RBD)问卷。临床评估:疾病持续时间、临床严重程度(统一亨廷顿病运动评定量表[UHDMRS])、基因检测。基于实验室的整夜视频多导睡眠图监测(V-PSG)。
疾病持续时间为9.4±4.4年,UHMDRS评分为55.5±23.4,CAG重复序列为44.3±4.1。体重指数为21.9±4.0kg/m²。无患者或照料者报告睡眠质量差。2例患者报告有RLS症状。8例患者ESS评分≥9分。8例患者有阻塞性睡眠呼吸暂停高风险。在RBD问卷中,2例患者评分异常。与对照组相比,HD患者睡眠时间更短,睡眠效率指数降低,觉醒和清醒次数增加。4例患者出现睡眠呼吸紊乱(SDB)。所有患者在清醒和睡眠期间均观察到周期性肢体运动(PLM)。在V-PSG记录中未观察到RBD发作,且无患者出现无张力的快速眼动(REM)睡眠。疾病持续时间与ESS评分相关(P<0.02)。UHMDRS与ESS评分呈正相关(P<0.005),与REM睡眠百分比呈负相关。
亨廷顿病患者存在严重的睡眠紊乱及周期性肢体运动的高患病率,但无睡眠呼吸紊乱或快速眼动睡眠行为障碍的证据。